0001127602-13-030657.txt : 20131105
0001127602-13-030657.hdr.sgml : 20131105
20131105170247
ACCESSION NUMBER: 0001127602-13-030657
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131104
FILED AS OF DATE: 20131105
DATE AS OF CHANGE: 20131105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: TREASURY BUILDING
STREET 2: LOWER GRAND CANAL STREET
CITY: DUBLIN 2
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-649-2000
MAIL ADDRESS:
STREET 1: TREASURY BUILDING
STREET 2: LOWER GRAND CANAL STREET
CITY: DUBLIN 2
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Botkin James L
CENTRAL INDEX KEY: 0001529873
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 131193428
MAIL ADDRESS:
STREET 1: 33 NORTHEAST COVE ROAD
CITY: DAWSONVILLE
STATE: GA
ZIP: 30534
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2013-11-04
0001520262
Alkermes plc.
ALKS
0001529873
Botkin James L
1300 GOULD DRIVE
GAINESVILLE
GA
30504
1
SVP, Alkermes Gainesville LLC
Ordinary Shares
2013-11-04
4
M
0
11000
14.60
A
13509
D
Ordinary Shares
2013-11-04
4
S
0
11000
35.4432
D
2509
D
Employee Stock Option (Right to Buy)
14.60
2013-11-04
4
M
0
11000
0
D
2012-10-05
2021-10-05
Ordinary Shares
11000
67000
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.245 to $35.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The option becomes exercisable in three annual installments: 33,000 vesting on 10/5/2012, 33,000 vesting on 10/5/2013 and 34,000 vesting on 10/5/2014.
/s/ Jennifer Baptiste, attorney-in-fact for James L Botkin
2013-11-05